Inhibition of urokinase-type plasminogen activator (upa)...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/19 (2006.01) A61P 35/00 (2006.01) C12Q 1/02 (2006.01) G01N 33/566 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2703184

The invention concerns methods for inhibiting the binding of urokinase-type plasminogen activator (uPA) to its receptor uPAR and/or inhibiting uPA biological activity. The invention further concerns methods for inhibiting tumor formation or metastasis, angiogenesis, such as tumor angiogenesis, and screening assays for identifying CYTL1 agonists.

Les procédés de l'invention permettent d'inhiber la liaison de l'activateur du plasminogène de type urokinase (uPA) à son récepteur uPAR et/ou d'inhiber l'activité biologique de l'uPA. Cette invention concerne, en outre, des procédés permettant d'inhiber la formation de tumeur ou la métastase, l'angiogenèse, telle que l'angiogenèse tumorale, et des dosages de type criblage pour identifier des agonistes CYTL1.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of urokinase-type plasminogen activator (upa)... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of urokinase-type plasminogen activator (upa)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of urokinase-type plasminogen activator (upa)... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1454456

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.